Warfarin resistance with poor CYP2C9 activity and CYP2C9*1*2 genotype.
Dericioglu
Nese
N
Babaoglu
Melih O
MO
Saygi
Serap
S
Bozkurt
Atila
A
Yasar
Umit
U
D000328:Adult; D000925:Anticoagulants / Q000008:administration & dosage / Q000493:pharmacokinetics*; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics* / Q000378:metabolism; D065729:Cytochrome P-450 CYP2C9; D004351:Drug Resistance; D005260:Female; D006801:Humans; D019934:International Normalized Ratio; D011110:Polymorphism, Genetic; D014859:Warfarin / Q000008:administration & dosage / Q000493:pharmacokinetics*
D000925:Anticoagulants; D014859:Warfarin; C450260:CYP2C9 protein, human; D065729:Cytochrome P-450 CYP2C9; D001189:Aryl Hydrocarbon Hydroxylases